anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Monroes Sequence

Arc collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 33,236
Current window 13,861-13,890
Pages 1,108
Rows per page 30
Arc: Monroes Sequenceclear collectionreset all
18 30 60

Arc

13,861-13,890 of 33,236

filter-aware
19
The slide uses a three-column layout to categorize clinical progress. SITC refers to the Society for Immunotherapy of Cancer conference.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
20
Includes a process flow diagram illustrating the current standard of care and patient outcomes.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
21
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
22
Includes reference to Nature publication and SITC 2021 presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
23
Includes trial schema (Part 1/2) and summary of patient characteristics, adverse events, and immune responses.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
24
The slide illustrates a dual-component therapy (CAR-T + RNA vaccine) and a multi-part clinical trial design.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
25
Slide 25 of a BioNTech presentation.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
26
Includes a diagram of the mechanism of action and a process flow for the clinical trial.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
27
The slide highlights immune activation markers and clinical disease control correlations, setting the stage for a Phase 2 trial.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
28
The slide outlines the mechanism of a bispecific antibody and the trial structure (dose escalation followed by expansion cohorts).BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
29
Clinical trial data summary slide.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
30
The slide uses a process flow diagram to describe the study design and three summary boxes for key clinical findings.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
31
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
32
The table shows a significant increase in commercial revenues and profit for 2021 compared to 2020.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
33
The chart breaks down revenue into four categories, with COVID-19 vaccine revenues being the primary driver.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
34
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
35
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
36
The slide uses a list-based structure to explain the acquisition of PhagoMed by BioNTech.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
37
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
38
The table uses a Gantt-style visualization for clinical trial phases, though all shown candidates are currently in Phase 1/2.BioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
39
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
40
BioNTech | Results Presentation Deck | 40 slidesBioNTech | Results Presentation Deck | 40 slides · BioNTech
Conference presentation Investor relations Beat · Action1 hit
03
Blue Apron | Results Presentation Deck | 18 slidesBlue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations Beat · Attention1 hit
04
Blue Apron | Results Presentation Deck | 18 slidesBlue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations Beat · Attention1 hit
06
Blue Apron | Results Presentation Deck | 18 slidesBlue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
07
The slide uses a standard ESG framework to categorize corporate initiatives.Blue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
08
Blue Apron | Results Presentation Deck | 18 slidesBlue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
09
Blue Apron | Results Presentation Deck | 18 slidesBlue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
11
Includes YoY growth metrics for the most recent quarter.Blue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
12
The slide uses a line chart for margin trends and a bar chart for PTG&A expenses with a table row for % of Net Revenue.Blue Apron | Results Presentation Deck | 18 slides · Blue Apron
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit